跳至主要内容
临床试验/NL-OMON40232
NL-OMON40232已完成3 期

Cytokine inhibition in Chronic Fatigue Syndrome patients - a pilot study - CiCFS

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • CDC-diagnosed CFS-patients
  • female, between 18 and 59 years old
  • fatigue duration <=10 years, or significant increase of complaints during the last 10 years
  • CIS (Checklist Individual Strength) >= 40
  • marked functional impairment: Sickness Impact Profile (SIP-8) >= 700

排除标准

  • pregnant or nursing women
  • women who intent to get pregnant during the study
  • fatigue duration >10 years
  • patients who use or have used psychotropic medication in the past month
  • substance abuse in the past 3 months
  • patients taking any medication except oral contraceptives and/or paracetamol
  • patients with evident somatic co-morbidity
  • previous or current engagement in CFS research
  • inability to understand the nature and the extent of the trial and the procedure required
  • psychiatric co-morbidity (major depression, psychosis, eating disorders, anxiety disorders, bipolar disease and post traumatic stress disorder) assessed with the MINI
  • live vaccination during the past four weeks
  • current engagement in a legal procedure

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验

Cytokine inhibition in Chronic Fatigue Syndrome... | 临床试验